StonvexLoading…
StonvexStonvexStonvexCore line items from XPEL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-04 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $137.78M | $117.35M | $476.20M | $353.93M | $228.52M |
Operating Income | Not available | $13.01M | $62.65M | $47.17M | $30.42M |
Net Income | Not available | $10.35M | $51.23M | $37.82M | $24.88M |
EPS (Diluted) | $0.62 | $0.37 | $1.85 | $1.37 | $0.90 |
Total Assets | Not available | $394.45M | $382.53M | $387.69M | $318.07M |
Total Liabilities | Not available | $101.86M | $97.34M | $113.84M | $62.41M |
Cash & Equivalents | Not available | $45.11M | $50.86M | $64.50M | $49.59M |
Free Cash Flow OCF − CapEx | Not available | $-2.34M | $62.93M | $61.34M | $29.17M |
Shares Outstanding | Not available | 27.56M | 27.60M | 27.68M | 27.65M |